QART Medical

Company Overview

Snapshot

Founded in April 2018 by Alon Shalev and Prof. Natan, QART Medical operates with 1–10 employees. The company has secured funding across multiple rounds from 4 investors, with The Chartered Group participating as a lead investor.

Business overview

QART Medical is a clinical-stage company developing a solution for the characterization and selection of sperm cells for in vitro fertilization (IVF). Its core technology is the QART system, a compact, stand-alone benchtop clinical workstation that uses a built-in quantitative phase interferometric microscopy (IPM) imaging platform and a microfluidics sorting stage. This system provides stain-free, real-time 3D topographic imaging to quantitatively characterize the morphology and contents of individual sperm cells, offering objective criteria for sorting semen samples. The company primarily serves the healthcare industry, specifically targeting clinics and hospitals involved in fertility treatments and women's health within the Health Tech & Life Sciences sector.

Strategic signal

In February 2025, news reports highlighted that QART Medical's technology, developed in collaboration with Tel Aviv University, has shown the potential to double IVF success rates. This indicates significant progress in the company's clinical development and validates the efficacy of its 3D imaging system for sperm selection. For investors, this signals a strong potential for market disruption in the fertility sector, offering a more effective solution for couples struggling with infertility and potentially accelerating the company's path to commercialization and broader adoption.

Company Intelligence Q&A

What is QART Medical's primary focus?

QART Medical is a clinical-stage company developing a solution for the highly informative characterization and selection of sperm cells for in vitro fertilization (IVF).

When was QART Medical founded and by whom?

QART Medical was founded in April 2018 by Alon Shalev and Prof. Natan.

What is the core technology behind the QART system?

The QART system is based on a built-in quantitative phase interferometric microscopy (IPM) imaging platform combined with a microfluidics sorting stage, enabling stain-free, real-time 3D topographic imaging of individual sperm cells.

What significant recognition did QART Medical receive in 2023?

In February 2023, QART Medical was among the winners at the 2023 SPIE Startup Challenge.